Godrej Industries Limited (GODREJIND)
Large CapDiversified stocks · Large cap · NSE
Godrej Industries Limited is a diversified Indian conglomerate with own businesses in Chemicals, Estate Management, and Finance & Investments. It also holds significant stakes in listed subsidiaries: Godrej Consumer Products (FMCG), Godrej Properties (Real Estate), and Godrej Agrovet (Agri-business).
One read, four checks
75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.
Weak fundamentals, management trust needs verification, price trend is neutral, and recent execution is mixed.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
low confidence · 0/0 claims checked
Timing lens: price trend and sector relative strength.
Rolling lens: recent quarterly delivery, not the latest single-result score.
Quarter ended 30 Jun 2026
Bad · 15/100PAT -28% YoY · Rev +22% YoY · margin expansion
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹5,448 Cr | +22.1% | -29.2% |
| EBITDA | ₹575 Cr | +44.8% | -50.7% |
| Operating margin | 11.0% | +200 bps | -400 bps |
| PAT | ₹523 Cr | -27.9% | -37.8% |
| PAT margin | 9.6% | -666 bps | -133 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Business & thesis
Growth engines, tailwinds/headwinds, and risk radar from management commentary
Business & thesis
Growth engines, tailwinds/headwinds, and risk radar from management commentary
Where growth can come from, and what can break the case
Godrej Industries reported robust Q4 FY26 consolidated performance with Total Income up 29% YoY to ₹8,274 crore and Net Profit surging 143% YoY to ₹444 crore. Full-year FY26 Total Income grew 19% to ₹25,981 crore, with Net Profit up 26% to ₹1,241 crore.
Strong consolidated financial performance in Q4 and FY26, driven by robust growth across key subsidiaries like Godrej Properties and Godrej Consumer Products, and improved profitability in Chemicals and Agrovet. The diversified portfolio appears to be executing well.
Q4 FY26 Revenue by Segment
Latest issuer-disclosed distribution across 5 reported categories.
Real Estate (GPL) Booking Value
Booking value grew 16% YoY and at a 3-year CAGR of 41% to ₹ 34,171 crore in FY26. Q4FY26 booking value was the highest ever quarterly bookings by GPL.
GCPL Home Care & Fabric Care
Home Care grew by 12%. Household Insecticides delivered strong broad-based growth. Fabric Care maintained robust double-digit growth momentum.
GAVL Animal Nutrition Volume
Q4 FY26 saw accelerated, broad-based volume growth of ~15% year-on-year across most categories, with cattle feed volumes rising sharply by 24% year-on-year.
Chemicals Revenue & Volume
Revenue for Q4 FY26 increased by 16%. Sales Volume grew by 9% in FY26.
GPL New Project Additions
GPL has added 18 new projects in FY26 with a total estimated saleable area of approximately 33.32 million sq. ft. and total estimated booking value potential of ~ ₹ 42,100 crore.
Chemicals Application Lab
NG Star Application Lab in Ambernath-Maharashtra supports product development, application testing, and technical collaboration.
GCPL Market Share Gains
Household Insecticides, Fabric Care, Soaps, and Hair Colour continue to gain market share consistently driven by strong in-market execution.
GAVL Operational Efficiencies
Vegetable Oil segment mitigated higher input costs impact through improved oil extraction ratio & other operational efficiencies.
GAVL Vegetable Oil Input Costs
Vegetable Oil segment margin was marginally lower on account of higher input costs.
Management accountability
What management said, and what results must prove
Management accountability
What management said, and what results must prove
What management said, and what results must prove
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
Q4 YoY comparison is crucial for understanding recent momentum and seasonal impacts, especially for consumer and agri businesses. FY26 YoY provides a full-year perspective on overall growth and profitability trends across the diversified portfolio.
GCPL Consolidated Sales Growth (Q4 FY26)
Q4 FY 2026 consolidated sales grew by 11% year-on-year on the back of underlying volume growth of 6%
GCPL Home Care Growth (Q4 FY26)
Home Care grew by 12%.
GCPL Personal Care Growth (Q4 FY26)
Personal Care grew by 3%
Chemicals Revenue Growth (Q4 FY26)
Revenue for Q4 FY26 increased by 16%
GPL Project Pipeline
GPL has added 18 new projects in FY26 with a total estimated saleable area of approximately 33.32 million sq. ft. and total estimated booking value potential of ~ ₹ 42,100 crore.
GCPL Premiumization & Market Share Focus
Skin Cleansing continues to upgrade to premium formats. Soaps and Hair Colour continue to win competitively and gain market share.
Chemicals Product Development Support
The NG Star Application Lab supports product development, application testing, and technical collaboration to translate chemistry into real world performance.
Numbers and claims to verify in the next filings
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| GPL Booking Value | ₹ 34,171 crore in FY26 | Sustained growth in booking value and successful monetization of new project additions. |
| GCPL Volume Growth | Underlying volume growth of 6% in Q4 FY26 | Continued underlying volume growth across key categories, especially Home Care and Personal Care. |
| GAVL Animal Nutrition Volume | Volume growth of ~15% year-on-year in Q4 FY26 | Maintenance of accelerated volume growth in Animal Nutrition, particularly cattle feed. |
| Chemicals PBIT Margin | 3.6% in Q4 FY26 (vs. 7.8% in Q4 FY25 and 7.4% in FY26) | Improvement in Chemicals PBIT margin, which saw a significant sequential decline in Q4 FY26. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trend score and candlestick chart
48NeutralSMA20 -10.1% / mo · MACD −
Technical chart
GODREJINDdaily · 1Y · AUTO+24.8%Daily technical trend read
Mixed signalsSignals are conflicting — long-term uptrend intact. RSI 41. Wait for confirmation.
- Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
- SMA20 falling (~11.2% over last month) — short-term momentum negative.
- RSI(14) at 41 — rising, no extreme reading.
- MACD below signal but histogram contracting — bearish momentum easing.
- 19% off 52W high · 56% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Relative Strength & Trend Stage
- Price is 7.8% above the 30-week proxy.
- The 50-DMA is above the 30-week proxy and its slope is rising +2.6%.
- Both 3-month and 6-month returns are positive.
Valuation & score drivers
U-Score 19 · OVERVALUED · pillar breakdown, sector model, fair-value anchor
Valuation & score drivers
U-Score 19 · OVERVALUED · pillar breakdown, sector model, fair-value anchor
Fundamental score breakdown
OVERVALUEDWhy this score?
Top U-Score contributors and drags from the latest stored fundamentals.
Positive drivers
- Growth contributes 14/25 to the score.
- Cash flow contributes 2/10 to the score.
- Quality contributes 2/20 to the score.
Main drags
- Altman Z is 0.6, in distress territory.
- Fair-value margin of safety is negative at -30.4%.
- Valuation is weaker at 0/30; verify the latest quarterly trend.
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Score history
12 stored score snapshots. Latest stored move: +0 points.
Factor attribution
Modelled fair value
Trust score
Does management behaviour match later outcomes? Claim delivery, forensic breakdown, evidence depth
Trust score
Does management behaviour match later outcomes? Claim delivery, forensic breakdown, evidence depth
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Weak Trust: Claim history is still being built. It ranks around the 10th percentile of the scored universe and 17th percentile within Diversified. Main check: balance sheet trust is weak at 8/100.
Mixed Trust Lite: Promoter holding is 74.6%. Key concern: Operating cash flow is negative at ₹-8855 Cr.
Management or financial behaviour needs caution. Demand stronger valuation compensation.
overall median 67 · Diversified: 17th pctile, median 61 · Large: 5th pctile, median 73
82 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Weak Trust · low confidenceRead Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust positives
- ▸Promoter holding is 74.6%.
- ▸Promoter pledge is zero.
- ▸Promoter holding increased 3.3%.
- ▸4/4 latest quarters had positive YoY revenue growth.
Trust risks
- ▸Operating cash flow is negative at ₹-8855 Cr.
- ▸Debt/equity is 4.61.
- ▸Altman Z is 0.61.
- ▸Interest coverage is 0.9x.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Financials
Full fundamentals table and 10-year revenue / profit / ROE history
Financials
Full fundamentals table and 10-year revenue / profit / ROE history
Fundamentals
Valuation
- P/E
- 32.60
- P/B
- 3.51
- EV/EBITDA
- 30.87
- Market Cap
- 39193.00Cr
Profitability
- ROE
- 9.26%
- ROCE
- 8.17%
- ROA
- 1.76%
- Dividend Y
- —
Growth (CAGR)
- Revenue 5Y
- 19.00%
- EPS 5Y
- 26.00%
- Revenue 3Y
- 10.00%
- EPS 3Y
- 5.00%
Balance Sheet
- Debt/Equity
- 4.61
- Interest Coverage
- 0.92×
- Altman Z
- 0.61
- Book Value
- 332.00
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 3/5
- OCF
- -8855.00 Cr
- EPS TTM
- 34.90
Shareholding
- Promoter Hold
- 74.64%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 60%
Financial History
Updated 5/9/2026
Revenue
₹ CrNet Profit
₹ CrReturn on Equity
%Peers
Business-comparable names in Diversified, ranked by similarity
Peers
Business-comparable names in Diversified, ranked by similarity
Peers
Business-comparable peers in Diversified — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.